Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 6 | 2023 | 767 | 0.990 |
Why?
|
| Iceland | 16 | 2024 | 20 | 0.930 |
Why?
|
| Genome-Wide Association Study | 15 | 2024 | 1671 | 0.920 |
Why?
|
| Genotyping Techniques | 2 | 2019 | 69 | 0.810 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 4 | 0.700 |
Why?
|
| Software | 2 | 2019 | 665 | 0.540 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 2340 | 0.530 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2024 | 2401 | 0.520 |
Why?
|
| Blood Proteins | 2 | 2023 | 146 | 0.410 |
Why?
|
| Genetic Variation | 5 | 2022 | 1374 | 0.390 |
Why?
|
| United Kingdom | 7 | 2024 | 164 | 0.350 |
Why?
|
| Phenotype | 5 | 2023 | 2440 | 0.350 |
Why?
|
| Databases, Genetic | 2 | 2022 | 263 | 0.340 |
Why?
|
| Homozygote | 3 | 2024 | 204 | 0.330 |
Why?
|
| Genomics | 2 | 2023 | 762 | 0.290 |
Why?
|
| Proteomics | 3 | 2023 | 230 | 0.290 |
Why?
|
| Proteome | 3 | 2023 | 132 | 0.280 |
Why?
|
| Germ-Line Mutation | 3 | 2024 | 344 | 0.270 |
Why?
|
| Loss of Function Mutation | 3 | 2021 | 46 | 0.270 |
Why?
|
| Genotype | 4 | 2023 | 1849 | 0.260 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 608 | 0.250 |
Why?
|
| Biological Specimen Banks | 2 | 2023 | 65 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 319 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 304 | 0.250 |
Why?
|
| Whole Genome Sequencing | 2 | 2022 | 87 | 0.240 |
Why?
|
| Thyroiditis, Autoimmune | 2 | 2024 | 17 | 0.240 |
Why?
|
| Codon, Initiator | 1 | 2024 | 22 | 0.240 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2024 | 22 | 0.230 |
Why?
|
| Migraine with Aura | 1 | 2023 | 4 | 0.230 |
Why?
|
| Urticaria | 1 | 2023 | 14 | 0.220 |
Why?
|
| Migraine Disorders | 1 | 2023 | 40 | 0.220 |
Why?
|
| Humans | 30 | 2024 | 89349 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 200 | 0.210 |
Why?
|
| Case-Control Studies | 6 | 2024 | 1862 | 0.210 |
Why?
|
| RNA Splice Sites | 2 | 2020 | 57 | 0.210 |
Why?
|
| Antigens, CD | 1 | 2024 | 466 | 0.210 |
Why?
|
| Viral Vaccines | 1 | 2022 | 44 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 465 | 0.210 |
Why?
|
| Computer Graphics | 2 | 2019 | 100 | 0.210 |
Why?
|
| Genetic Loci | 2 | 2020 | 253 | 0.190 |
Why?
|
| Platelet Count | 1 | 2021 | 93 | 0.190 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2021 | 6 | 0.190 |
Why?
|
| Epidemics | 1 | 2021 | 34 | 0.190 |
Why?
|
| Penetrance | 1 | 2021 | 45 | 0.190 |
Why?
|
| Pedigree | 2 | 2020 | 970 | 0.190 |
Why?
|
| Disease | 1 | 2021 | 90 | 0.190 |
Why?
|
| Benchmarking | 1 | 2021 | 79 | 0.190 |
Why?
|
| Receptors, LDL | 1 | 2020 | 55 | 0.180 |
Why?
|
| Hearing Loss | 1 | 2021 | 59 | 0.180 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2021 | 61 | 0.180 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 54 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 170 | 0.180 |
Why?
|
| Wnt4 Protein | 1 | 2020 | 4 | 0.180 |
Why?
|
| Codon, Nonsense | 1 | 2020 | 44 | 0.180 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 39 | 0.180 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 66 | 0.170 |
Why?
|
| Gene Frequency | 4 | 2024 | 685 | 0.170 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2020 | 131 | 0.170 |
Why?
|
| Uterine Prolapse | 1 | 2020 | 80 | 0.170 |
Why?
|
| Peripherins | 1 | 2019 | 4 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 127 | 0.170 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 225 | 0.170 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 175 | 0.170 |
Why?
|
| Sural Nerve | 1 | 2019 | 19 | 0.170 |
Why?
|
| Workflow | 1 | 2019 | 80 | 0.170 |
Why?
|
| Epilepsy | 1 | 2023 | 424 | 0.170 |
Why?
|
| Neural Conduction | 1 | 2019 | 71 | 0.160 |
Why?
|
| Ligands | 1 | 2020 | 444 | 0.160 |
Why?
|
| Polyneuropathies | 1 | 2019 | 27 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2018 | 33 | 0.160 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 48 | 0.160 |
Why?
|
| Biomarkers | 2 | 2021 | 1767 | 0.150 |
Why?
|
| Alleles | 4 | 2024 | 1135 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 296 | 0.150 |
Why?
|
| Proteins | 1 | 2023 | 787 | 0.150 |
Why?
|
| Genetics, Population | 1 | 2019 | 406 | 0.140 |
Why?
|
| Base Sequence | 2 | 2017 | 2327 | 0.140 |
Why?
|
| Asthma | 1 | 2024 | 978 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 758 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 580 | 0.130 |
Why?
|
| Parents | 1 | 2018 | 285 | 0.130 |
Why?
|
| Mutation | 3 | 2023 | 4143 | 0.130 |
Why?
|
| Female | 13 | 2024 | 46200 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 866 | 0.120 |
Why?
|
| Haplotypes | 3 | 2022 | 637 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2018 | 657 | 0.110 |
Why?
|
| Transcriptome | 1 | 2018 | 630 | 0.110 |
Why?
|
| Male | 11 | 2024 | 42410 | 0.110 |
Why?
|
| Ireland | 2 | 2023 | 9 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2758 | 0.110 |
Why?
|
| Africa | 2 | 2023 | 101 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 25974 | 0.100 |
Why?
|
| Adult | 7 | 2024 | 26607 | 0.090 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 249 | 0.090 |
Why?
|
| HLA Antigens | 2 | 2024 | 227 | 0.090 |
Why?
|
| Vaccination | 2 | 2022 | 274 | 0.090 |
Why?
|
| RNA Splicing | 2 | 2023 | 152 | 0.090 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 309 | 0.090 |
Why?
|
| Aged | 6 | 2023 | 19165 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 3041 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1877 | 0.080 |
Why?
|
| Betacoronavirus | 2 | 2020 | 261 | 0.070 |
Why?
|
| Young Adult | 3 | 2024 | 6312 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2022 | 2017 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 9263 | 0.060 |
Why?
|
| Norway | 1 | 2024 | 10 | 0.060 |
Why?
|
| Denmark | 1 | 2024 | 17 | 0.060 |
Why?
|
| Vitiligo | 1 | 2024 | 17 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2024 | 51 | 0.060 |
Why?
|
| Receptors, IgG | 1 | 2024 | 53 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2024 | 132 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2024 | 111 | 0.060 |
Why?
|
| Menopause | 1 | 2024 | 76 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 773 | 0.060 |
Why?
|
| Plasma | 1 | 2023 | 51 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2869 | 0.060 |
Why?
|
| Datasets as Topic | 1 | 2023 | 75 | 0.060 |
Why?
|
| Mast Cells | 1 | 2023 | 94 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2023 | 87 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2023 | 166 | 0.050 |
Why?
|
| Autophagy | 1 | 2024 | 159 | 0.050 |
Why?
|
| INDEL Mutation | 1 | 2022 | 31 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 55 | 0.050 |
Why?
|
| Asia | 1 | 2022 | 98 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 18 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2022 | 23 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 148 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2022 | 211 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 299 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2022 | 226 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 53 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2021 | 16 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2020 | 13 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 155 | 0.050 |
Why?
|
| Child | 2 | 2024 | 7173 | 0.050 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2020 | 19 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 256 | 0.050 |
Why?
|
| Quarantine | 1 | 2020 | 8 | 0.050 |
Why?
|
| Exons | 1 | 2022 | 451 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 94 | 0.050 |
Why?
|
| Genes | 1 | 2021 | 305 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 160 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 119 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 317 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2020 | 29 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5498 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 275 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6811 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 71 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 373 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 342 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 211 | 0.040 |
Why?
|
| Introns | 1 | 2020 | 299 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2020 | 446 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2022 | 491 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 560 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 683 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 2018 | 7 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 471 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 66 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 595 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 312 | 0.040 |
Why?
|
| Axons | 1 | 2019 | 180 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 922 | 0.040 |
Why?
|
| CpG Islands | 1 | 2018 | 157 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1223 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 1208 | 0.040 |
Why?
|
| Pan paniscus | 1 | 2017 | 10 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 27369 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2021 | 537 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 353 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 1840 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 773 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 855 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 718 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 949 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 1870 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 551 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 477 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 636 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2496 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 481 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 793 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 374 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 3157 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3731 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2303 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3666 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 3384 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 11761 | 0.020 |
Why?
|